Interleukin-6 (Yeda)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInterleukin-6 (Yeda)
Drug Alias Namer-hIL6SJ0031IL-6β2-interferonRecombinant human interleukin-6 +[6] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionInterleukin-6 receptor alpha subunit agonistsInterleukin-6 receptor subunit beta agonists
TargetsInterleukin-6 receptor alpha subunitInterleukin-6 receptor subunit beta
Therapy Area/IndicationsThrombocytopeniaHematologic DiseasesHematologic Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesYeda Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesYeda PharmaMerck Serono
Active IndicationsN/A
Inactive IndicationsThrombocytopeniaHematologic DiseasesHematologic Neoplasms +[4] 

Other Information

ATC CodeN/A
Related LinksN/A